DXCM News and Press, DexCom Inc. From 01/14/24

2024-01-14 11:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Supported by strong st...

2024-01-09 07:15:00 ET Growth stocks were back in style in 2023 after a disappointing year in 2022. However, not every growth-oriented company kept pace with the broader indexes. Here are two that didn't: Sarepta Therapeutics (NASDAQ: SRPT) and DexCom (NASDAQ: DXCM) . These ...

2024-01-08 13:00:32 ET More on DexCom Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy DexCom: Q3 2023 Results Were Fantastic And I Remain Bullish Investors Take Note: DexCom Is Back! MedTech stocks gain after Novo Nordisk data ...

The company also announced Stelo, its new glucose sensor for people with type 2 diabetes who do not use insulin, has been submitted to the U.S. Food and Drug Administration for review and is expected to launch in the U.S. in summer 2024 DexCom, Inc. (Nasdaq: DXCM), the leader in rea...

2024-01-07 12:00:45 ET More on AbbVie, Bristol-Myers, etc. AbbVie: Still Expensive Despite The Great M&A Acumen Bristol-Myers Squibb Company (BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Health...

2024-01-07 09:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. With bond yields falli...

DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 42 nd annual J.P. Morgan Healthcare Conference on January 8, 2024. The live presentation is scheduled to begin at approximately 12:4...

2023-12-13 12:26:47 ET More on iShares MSCI ACWI ETF: ACWI: Lowered U.S. Exposure Finally A Plus BofA: The best ranked returns year-to-date for cross-asset goods Seeking Alpha’s Quant Rating on iShares MSCI ACWI ETF Dividend scorecard for iShares MSCI ...

2023-12-11 13:52:21 ET Summary DexCom is expected to remain an outperformer in the healthcare sector in 2024, driven by M&A activity and the growth of GLP-1 weight loss drugs. The company's continuous glucose monitoring ("CGM") solutions are complementary to GLP-1 therapies an...

2023-12-11 06:44:02 ET Summary The S&P 500 reached 4,600 for the first time since March 2022. The current bull plateau is strong enough to avoid a recession but sluggish enough for the plateau to last for at least 3 years. Cash cows on the bull plateau are helping instant ...